The most important problem in medicine, and the case for acting now.
Researchers have developed a new LiDAR approach that makes it possible to image small objects with much greater precision and accuracy than conventional LiDAR. The method could be useful for acquiring noncontact measurements of critical parts or features during manufacturing.
“LiDAR systems like the ones used in autonomous cars typically measure large objects like roads, cars and trees at large distances with an accuracy of a few centimeters,” said research team leader Derryck T. Reid from Heriot-Watt University in the U.K. “Our LiDAR imaging technique makes it possible to acquire measurements with much greater accuracy while maintaining fully electronic detection, which avoids the complexity and scalability challenges of some high-precision systems.”
In the journal Optics Letters, the researchers describe their new imaging technique, which is based on two-photon dual-comb ranging. They show that the approach can be used to create detailed 3D representations of small aluminum objects with micron-scale precision from 40 centimeters (16 inches) away.
Melatonin—a go-to sleep aid for kids and adults alike in many households in America— continues to create media buzz, with conflicting messages that leave people uncertain about its safety.
Some headlines point to melatonin’s supposed immunity-boosting power, while others point to unestablished links between melatonin and heart failure.
I’m a pediatrician and sleep medicine doctor specializing in children, adolescents and adults.
Hereditary hearing loss affects millions globally, with mutations in the SLC26A4 gene among the most common genetic triggers, particularly across Asian populations. This condition leads to severe-to-profound deafness accompanied by inner ear malformations, such as an abnormally enlarged vestibular aqueduct and endolymphatic sac.
While gene replacement therapies have long held immense potential, experimental interventions have historically been restricted to the embryonic stage. Delivering genetic material before birth presents steep ethical and practical hurdles, creating a critical roadblock for real-world medical applications.
A new study from UC San Francisco shows how certain cells in the brain may cause aneurysms to weaken and rupture. It helps explain why some aneurysms burst while others do not and could lead to new ways of predicting and possibly preventing strokes.
Brain aneurysms are bulges in blood vessels that can go unnoticed for years. If they rupture, they can cause a severe and often deadly type of stroke. About one in 50 Americans has a brain aneurysm, but doctors still struggle to predict which ones are most dangerous.
The new study helps to unpack the biology behind these events by mapping the cells in artery walls and the interactions that weaken them.
Endometriosis is a painful, common condition affecting women worldwide, but treatment and diagnosis options are scarce. A new University of Mississippi-led study may have found an answer to both problems.
Early results from a study published in Communications Chemistry show that gold-laced nanoparticles can hitchhike on white blood cells. By using those cells as a delivery vehicle, the team hopes to identify and treat endometriosis without repeated surgeries.
“Lots of women go through their lives being in enormous amounts of pain and thinking that it’s normal, and it’s not normal,” said Eden Tanner, assistant professor of chemistry and biochemistry, who authored the study with a team of Ole Miss researchers.
Engineers have developed a new way to monitor how tiny lab-grown human heart tissues beat—by effectively “listening” to the ripples they create. The team has created a wireless, noninvasive sensing platform that can biomechanically measure how strongly the miniature heart tissues, known as cardiac organoids, beat in real time. The research could help accelerate drug development, improve disease modeling and reduce reliance on animal testing, offering a more human-relevant way to study how the heart works.
Cardiac organoids are 3D clusters of human heart cells grown in a laboratory that are used to evaluate the safety and efficacy of new drugs prior to clinical trials, as well as study disease. While they don’t replicate the full structure of a human heart, they mimic key behaviors, especially how heart muscles contract when drugs are administered.
They are increasingly seen as a powerful alternative to animal models, which often fail to fully capture how human biology works.
BACKGROUND: Vascular smooth muscle cells (VSMCs) play a central role in atherosclerosis by undergoing phenotypic modulation from a quiescent, contractile state to a range of synthetic phenotypes, including fibroblast-like, macrophage-like, and lipid-laden foam cell–like states. However, a comprehensive multimodal characterization and understanding of the transcriptional programs driving these transitions remain incomplete. METHODS: To comprehensively define the phenotypic diversity of VSMCs during atherosclerosis progression, we performed in-depth profiling using cellular indexing of transcriptomes and epitopes by sequencing and bulk RNA sequencing in a VSMC-lineage–tracing atherosclerotic mouse model. Insights from these data sets guided the design of targeted in vitro experiments to investigate candidate regulatory mechanisms.
Plasma is an ionized gas, often referred to as the fourth state of matter. Plasmas, which are created artificially by applying energy to a gas, are found in the fluorescent tubes that illuminate kitchens. However, they have many other possible applications, such as the production of graphene.
The Plasma Innovation Laboratory (LIPs) at the University of Córdoba has already made progress in using plasma to produce graphene, the revolutionary material that earned its discoverers the Nobel Prize. Recently, a new technological design boosted graphene production by more than 22%. Continuing along this line of research, the team is now proposing two methods for applying graphene—also highly anticorrosive—to metal surfaces using microwave plasmas at atmospheric pressure, with the aim of not altering the properties of the metals.
The research is published in the journal Surfaces and Interfaces.
A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA vaccines generate immunity, revealing that certain non-immune cells help determine vaccine effectiveness.
The study, published in Nature Biotechnology, also introduces a powerful and versatile technology to control the expression of mRNA drugs, which the researchers demonstrate can enhance the effectiveness of mRNA cancer vaccines in preclinical studies of lymphoma. The paper is titled “mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression.”
The findings provide a new framework for designing mRNA vaccines and mRNA therapeutics, with immediate implications for cancer immunotherapy, infectious disease vaccines, and gene-editing treatments.